TY - JOUR
T1 - Semaphorin 7A promotes macrophage-mediated lymphatic remodeling during postpartum mammary gland involution and in breast cancer
AU - Elder, Alan M.
AU - Tamburini, Beth A.J.
AU - Crump, Lyndsey S.
AU - Black, Sarah A.
AU - Wessells, Veronica M.
AU - Schedin, Pepper J.
AU - Borges, Virginia F.
AU - Lyons, Traci R.
N1 - Funding Information:
Cancer League of Colorado AWD#173586-TL (T.R. Lyons, B.A.J. Tam-burini, A.M. Elder), Colorado Clinical Translational Sciences Institute KL2TR001080 (T.R. Lyons, S.A. Black, A.M. Elder), American Cancer Society RSG-16-171-010CSM (T.R. Lyons, A.M. Elder, L.S. Crump, V.M. Wessells), National Cancer Institute R01 CA211696-01A1 (T.R. Lyons, A.M. Elder, L.S. Crump, V.M. Wessells), R21CA185226-01 (T.R. Lyons, S.A. Black, V.M. Wessells), AACR-BCRF 09-06-26 (V.F. Borges, P.J. Schedin, V.M. Wessells), NIH1R01CA169175-01 (V.F. Borges, P.J. Schedin, T.R. Lyons, A.M. Elder, and V.M. Wessells), and Grohne Family Foundation Grant (V.F. Borges, P.J. Schedin, T.R. Lyons). Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core. L.S. Crump and T.R. Lyons were supported in part by NIH/NCATS Colorado CTSI Grant TR001082 and RR025780. Tissue Bio banking occurred in the Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant P30CA046934. The authors would also like to thank the following persons for all of their help in the production of this manuscript: Holly Martinson, Justin Pruitt, Charlene Tilton, Cera Neito, Kim Jordan, Michelle Borakove, Jeffrey Finlon, Gavin Ryan, Peter Hensen, and the UC Cohort Patients.
Funding Information:
Cancer League of Colorado AWD#173586-TL (T.R. Lyons, B.A.J. Tamburini, A.M. Elder), Colorado Clinical Translational Sciences Institute KL2TR001080 (T.R. Lyons, S.A. Black, A.M. Elder), American Cancer Society RSG-16-171-010CSM (T.R. Lyons, A.M. Elder, L.S. Crump, V.M. Wessells), National Cancer Institute R01 CA211696-01A1 (T.R. Lyons, A.M. Elder, L.S. Crump, V.M. Wessells), R21CA185226-01 (T.R. Lyons, S.A. Black, V.M. Wessells), AACR-BCRF 09-06-26 (V.F. Borges, P.J. Schedin, V.M. Wessells), NIH1R01CA169175-01 (V.F. Borges, P.J. Schedin, T.R. Lyons, A.M. Elder, and V.M. Wessells), and Grohne Family Foundation Grant (V.F. Borges, P.J. Schedin, T.R. Lyons). Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core. L.S. Crump and T.R. Lyons were supported in part by NIH/NCATS Colorado CTSI Grant TR001082 and RR025780. Tissue Bio banking occurred in the Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant P30CA046934. The authors would also like to thank the following persons for all of their help in the production of this manuscript: Holly Martinson, Justin Pruitt, Charlene Tilton, Cera Neito, Kim Jordan, Michelle Borakove, Jeffrey Finlon, Gavin Ryan, Peter Hensen, and the UC Cohort Patients.
Publisher Copyright:
©2018 American Association for Cancer Research.
PY - 2018/11/15
Y1 - 2018/11/15
N2 - Postpartum mammary gland involution is a tissue remodeling event that occurs in all mammals in the absence of nursing or after weaning to return the gland to the pre-preg-nant state. The tissue microenvironment created by involution has proven to be tumor promotional. Here we report that the GPI-linked protein semaphorin 7A (SEMA7A) is expressed on mammary epithelial cells during involution and use preclinical models to demonstrate that tumors induced during involution express high levels of SEMA7A. Overexpression of SEMA7A promoted the presence of myeloid-derived podoplanin (PDPN)-expressing cells in the tumor microenvironment and during involution. SEMA7A drove the expression of PDPN in macrophages, which led to integrin- and PDPN-dependent motility and adherence to lymphatic endothelial cells to promote lymphangiogenesis. In support of this mechanism, mammary tissue from SEMA7A-knockout mice exhibited decreased myeloid-derived PDPN-expressing cells, PDPN-expressing endothelial cells, and lymphatic vessel density. Furthermore, coexpression of SEMA7A, PDPN, and macrophage marker CD68 predicted for decreased distant metastasis-free survival in a cohort of over 600 cases of breast cancer as well as in ovarian, lung, and gastric cancers. Together, our results indicate that SEMA7A may orchestrate macrophage-mediated lymphatic vessel remodeling, which in turn drives metastasis in breast cancer. Signficance: SEMA7A, which is expressed on mammary cells during glandular involution, alters macrophage biology and lymphangiogenesis to drive breast cancer metastasis.
AB - Postpartum mammary gland involution is a tissue remodeling event that occurs in all mammals in the absence of nursing or after weaning to return the gland to the pre-preg-nant state. The tissue microenvironment created by involution has proven to be tumor promotional. Here we report that the GPI-linked protein semaphorin 7A (SEMA7A) is expressed on mammary epithelial cells during involution and use preclinical models to demonstrate that tumors induced during involution express high levels of SEMA7A. Overexpression of SEMA7A promoted the presence of myeloid-derived podoplanin (PDPN)-expressing cells in the tumor microenvironment and during involution. SEMA7A drove the expression of PDPN in macrophages, which led to integrin- and PDPN-dependent motility and adherence to lymphatic endothelial cells to promote lymphangiogenesis. In support of this mechanism, mammary tissue from SEMA7A-knockout mice exhibited decreased myeloid-derived PDPN-expressing cells, PDPN-expressing endothelial cells, and lymphatic vessel density. Furthermore, coexpression of SEMA7A, PDPN, and macrophage marker CD68 predicted for decreased distant metastasis-free survival in a cohort of over 600 cases of breast cancer as well as in ovarian, lung, and gastric cancers. Together, our results indicate that SEMA7A may orchestrate macrophage-mediated lymphatic vessel remodeling, which in turn drives metastasis in breast cancer. Signficance: SEMA7A, which is expressed on mammary cells during glandular involution, alters macrophage biology and lymphangiogenesis to drive breast cancer metastasis.
UR - http://www.scopus.com/inward/record.url?scp=85056571435&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056571435&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-18-1642
DO - 10.1158/0008-5472.CAN-18-1642
M3 - Article
C2 - 30254150
AN - SCOPUS:85056571435
SN - 0008-5472
VL - 78
SP - 6473
EP - 6485
JO - Cancer Research
JF - Cancer Research
IS - 22
ER -